Subscribe to RSS
DOI: 10.1055/s-0040-1718952
Advantages and Disadvantages of Medical Abortion, According to Brazilian Residents in Obstetrics and Gynaecology
Vantagens e desvantagens do aborto medicamentoso, segundo os residentes brasileiros em ginecologia e obstetrícia
Abstract
Objective To find out which was the opinion of residents in obstetrics and gynecology about the advantages and disadvantages of medical abortion as compared with surgical procedures.
Method Cross-sectional multicenter study among residents in obstetrics and gynecology from 21 maternity hospitals located in 4 different geographical regions of Brazil, using a self-responded questionnaire with 31 questions related to their opinion and experience on providing abortion services.
Results Most residents agreed that “being less invasive” (94.7%), “does not require anesthesia” (89.7%), “can be accompanied during the process” (89.1%), “prevents physical trauma” (84.4%) were the main advantages of medical abortion.
Conclusion Residents perceived both clinical and personal issues as advantages of medical abortion.
Resumo
Objetivo Descobrir qual foi a opinião dos residentes em ginecologia e obstetrícia sobre as vantagens e desvantagens do aborto medicamentoso em relação aos procedimentos cirúrgicos.
Métodos Estudo multicêntrico transversal entre residentes de ginecologia e obstetrícia de 21 maternidades localizadas em 4 diferentes regiões geográficas do Brasil, utilizando um questionário autorrespondido com 31 questões relacionadas à sua opinião e experiência na prestação de serviços de aborto.
Resultados A maioria dos residentes concordou que "ser menos invasivo" (94,7%), "não necessitar de anestesia" (89,7%), "poder ser acompanhado durante o processo" (89,1%), "prevenir trauma físico" (84,4%) foram as principais vantagens do aborto medicamentoso.
Conclusão Os residentes perceberam tanto questões clínicas como pessoais como sendo vantagens do aborto medicamentoso.
Contributions
Faúndes A. and Pacagnella R. C. led the study from its conceptualization, organizing the data collection and data analysis and writing the paper. Duarte G. A. and Osis M. J. D. contributed to the conceptualization and planning of the study and participated in the critical review of the manuscript at all stages up to its final approval. Bento S. F., Fernandes K. G. and Pádua K. S. contributed to the analysis and interpretation of the data and participated in the preparation of the manuscript and its critical review at all stages until its final approval.
Publication History
Received: 10 January 2020
Accepted: 14 September 2020
Article published online:
21 December 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Boland R, Katzive L. Developments in laws on induced abortion: 1998-2007. Int Fam Plan Perspect 2008; 34 (03) 110-120
- 2 Diniz D, Medeiros M, Madeiro A. National abortion survey 2016. Cien Saude Colet 2017; 22 (02) 653-660
- 3 Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B. et al. Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet 2016; 388 (10041): 258-267
- 4 Diniz D, Brito L, Ambrogi I, Tavares AB, Ali M. Understanding the sexual and reproductive health needs in Brazil's Zika-affected region: placing women at the center of the discussion. Int J Gynaecol Obstet 2019; 147 (02) 268-270
- 5 Malta M, Wells S, LeGrand S, Seixas M, Baptista A, Silva CMFP. et al. Abortion in Brazil: the case for women's rights, lives, and choices. Lancet Public Health 2019; 4 (11) e552
- 6 Grimes DA, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, Shah IH. l. Unsafe abortion: the preventable pandemic. Lancet 2006; 368 (9550): 1908-1919
- 7 Faúndes A. Misoprostol: life-saving. Eur J Contracept Reprod Health Care 2011; 16 (02) 57-60
- 8 Silva DFO, Bedone AJ, Faúndes A, Fernandes AMS, Lima e Moura VGA. Aborto provocado: redução da frequência e gravidade das complicações. Consequência do uso de misoprostol?. Rev Bras Saúde Mater Infant 2010; 10 (04) 441-447
- 9 Faúndes A, Bedone A, Silva JLP. I Fórum interprofissional para implementação do atendimento ao aborto previsto por lei: relatório final. Femina 1997; 25 (01) 69-78
- 10 Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Ações Programáticas Estratégicas. Norma técnica: prevenção e tratamento dos agravos resultantes da violência sexual contra mulheres e adolescentes. Brasília (DF): Ministério da Saúde; 2010
- 11 Faúndes A, Araújo MJO, Andalaft Neto J, Ferreira MFO. Relatório final: X Fórum interprofissional sobre violência contra a mulher e implementação do aborto previsto na lei. Femina 2007; 35 (01) 55-58
- 12 Faúndes A, Duarte GA, Osis MJD, Andalaft Neto J. [Knowledge and opinion variations of Brazilian obstetricians and gynecologists face to legal abortion, between 2003 and 2005]. Rev Bras Ginecol Obstet 2007; 29 (04) 192-199
- 13 Fiol V, Rieppi L, Aguirre R, Nozar M, Gorgoroso M, Coppola F, Briozzo L. The role of medical abortion in the implementation of the law on voluntary termination of pregnancy in Uruguay. Int J Gynaecol Obstet 2016; 134 (Suppl. 01) S12-S15
- 14 Ganatra B, Tunçalp Ö, Johnston HB, Johnson Jr BR, Gülmezoglu AM, Temmerman M. From concept to measurement: operationalizing WHO's definition of unsafe abortion. Bull World Health Organ 2014; 92 (03) 155
- 15 Palma Manríquez I, Moreno Standen C, Álvarez Carimoney A, Richards A. Experience of clandestine use of medical abortion among university students in Chile: a qualitative study. Contraception 2018; 97 (02) 100-107
- 16 World Health Organization. Preventing unsafe abortion. Geneva: WHO; 2018
- 17 Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2011; (11) CD002855
- 18 World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed.. Geneva: WHO; 2012
- 19 Ireland LD, Gatter M, Chen AY. Medical compared with surgical abortion for effective pregnancy termination in the first trimester. Obstet Gynecol 2015; 126 (01) 22-28
- 20 Laursen L, Stumbras K, Lewnard I, Haider S. Contraceptive provision after medication and surgical abortion. Womens Health Issues 2017; 27 (05) 546-550
- 21 Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Ações Programáticas Estratégicas. Prevenção e tratamento dos agravos resultantes da violência sexual contra mulheres e adolescentes: norma técnica. 3a ed.. Brasília (DF): Ministério da Saúde; 2012
- 22 Pacagnella RC, Bento SF, Fernandes KG, Araújo DM, Fahl ID, Fanton TF. et al; Grupo de Estudos sobre Aborto no Brasil. Knowledge on medical abortion among Brazilian medical residents in Gynecology and Obstetrics. Cad Saude Publica 2020; 36 (36) (Suppl. 01) e00187918
- 23 R Core Team. R: a language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2017 [cited 2017 Mar 6]. Available from: http://www. www.R-project.org/
- 24 Ho PC. Women's perceptions on medical abortion. Contraception 2006; 74 (01) 11-15
- 25 Saurel-Cubizolles MJ, Opatowski M, David P, Bardy F, Dunbavand A. Pain during medical abortion: a multicenter study in France. Eur J Obstet Gynecol Reprod Biol 2015; 194: 212-217
- 26 Platais I, Tsereteli T, Grebennikova G, Lotarevich T, Winikoff B. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan. Int J Gynaecol Obstet 2016; 134 (03) 268-271
- 27 Winikoff B, Dzuba IG, Chong E, Goldberg AB, Lichtenberg ES, Ball C. et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet Gynecol 2012; 120 (05) 1070-1076